Filing Details

Accession Number:
0001179110-11-015806
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-30 20:34:08
Reporting Period:
2011-11-28
Filing Date:
2011-11-30
Accepted Time:
2011-11-30 20:34:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1061027 Sunesis Pharmaceuticals Inc SNSS Pharmaceutical Preparations (2834) 943295878
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1323113 Jr N Daniel Swisher C/o Sunesis Pharmaceuticals, Inc.
395 Oyster Point Blvd., Ste. 400
South San Francisco CA 94080
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-28 2,500 $1.14 127,176 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 39,605 Direct
Footnotes
  1. The Shares are held by the Swisher Revocable Trust for which reporting person is Trustee.
  2. The amount of securities beneficially owned by the reporting person were incorrectly allocated between direct and indirect holdings in previous reports. The amount of securities beneficially owned by the reporting person following the reported transaction have been adjusted to reflect the correct allocations for the reporting person's direct and indirect holdings.
  3. Includes 5,936 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2011.